Bremworth (BRW) H2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2026 earnings summary
31 Aug, 2026Executive summary
Revenue increased 21% year-over-year to $106.6m, primarily driven by strong performance in the Elco Direct wool sourcing business.
Gross margin improved by 0.7 percentage points to 13.7% year-over-year.
Net loss after tax was $(11.4)m, including $(1.9)m in one-off items related to insurance, restructuring, and contract provisions.
Normalised EBIT loss improved from $(15.9)m to $(9.4)m year-over-year.
Operational reset initiatives focused on cost reduction, inventory quality, and commercial excellence.
Financial highlights
Available cash at year-end was $22.0m, with no borrowings.
Operating cash outflow (excluding insurance-related items) was $(9.3)m, a $14.5m improvement from the prior year.
Year-end inventory stood at $29.1m, up from $28.0m in the previous year.
Outlook and guidance
Focus has shifted from rebuilding to growth, with expectations of improved financial performance in FY27 as benefits from revenue and cost initiatives materialize.
The company is positioned to benefit from a recovery in residential construction and renovation activity, with additional growth opportunities in North America and China.
Immediate objectives are to return to profitability and positive operating cash flow while maintaining disciplined cash management.
Latest events from Bremworth
- Revenue up 6.1% but losses persist, margins pressured, and no dividend declared.BRW
H1 2026 - Shareholders approved all resolutions as the board advanced a sale to Floorscape and operational turnaround.BRW
AGM 2025 - Revenue up, margins down; strategic investments target recovery amid tough market.BRW
H2 2025 - Revenue and profit fell in FY24, but growth and dividends are targeted for FY26.BRW
AGM 2024 - Profit fell to $4.6m as cyclone disruptions hit revenue, but growth initiatives are underway.BRW
H2 2024 - Revenue up 8% to $42.1m, but losses widened; insurance settlement supports FY26 recovery.BRW
H1 2025